EcoDrugPlus

60s Ribosomal Protein L30-Like

Ensembl ID : ENSPCTG00005007079
Gene Symbol: LOC102981543
3 Cross references
161 Possible Orthologues:

A-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSPCTG00005009037
Gene Symbol: ARAF
1 Cross references
190 Possible Orthologues:

Adrm1 26s Proteasome Ubiquitin Receptor

Ensembl ID : ENSPCTG00005014185
Gene Symbol: ADRM1
1 Cross references
255 Possible Orthologues:

Akt Serine/threonine Kinase 1

Ensembl ID : ENSPCTG00005006784
Gene Symbol: AKT1
3 Cross references
213 Possible Orthologues:

Akt Serine/threonine Kinase 2

Ensembl ID : ENSPCTG00005007740
Gene Symbol: AKT2
1 Cross references
252 Possible Orthologues:

Atp Binding Cassette Subfamily B Member 1

Ensembl ID : ENSPCTG00005003552
Gene Symbol: ABCB1
3 Cross references
161 Possible Orthologues:

Atp Binding Cassette Subfamily C Member 1

Ensembl ID : ENSPCTG00005022125
Gene Symbol: ABCC1
1 Cross references
201 Possible Orthologues:

Atp Binding Cassette Subfamily C Member 8

Ensembl ID : ENSPCTG00005004712
Gene Symbol: ABCC8
3 Cross references
237 Possible Orthologues:

Atp Binding Cassette Subfamily C Member 9

Ensembl ID : ENSPCTG00005015979
Gene Symbol: ABCC9
3 Cross references
229 Possible Orthologues:

Atpase H+/k+ Transporting Subunit Beta

Ensembl ID : ENSPCTG00005004620
Gene Symbol: ATP4B
3 Cross references
184 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 1

Ensembl ID : ENSPCTG00005018474
Gene Symbol: ATP1A1
3 Cross references
322 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 2

Ensembl ID : ENSPCTG00005002328
Gene Symbol: ATP1A2
2 Cross references
205 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).